MARCH6 inhibitors belong to a class of chemical compounds designed to target and modulate the activity of the Membrane-Associated RING-CH 6 (MARCH6) protein. MARCH6 is a member of the MARCH family of E3 ubiquitin ligases, which play a crucial role in the regulation of protein turnover and degradation within the cell. These enzymes are involved in a process called ubiquitination, where they attach ubiquitin molecules to specific target proteins, marking them for degradation by the proteasome or lysosome. MARCH6, in particular, is primarily associated with the regulation of membrane proteins, including various cell surface receptors and transporters. By inhibiting MARCH6 activity, researchers aim to better understand the role of this E3 ubiquitin ligase in cellular processes, particularly in the context of protein trafficking and degradation.
The study of MARCH6 inhibitors has significant implications in the field of cell biology and molecular biology. MARCH6-mediated ubiquitination and subsequent degradation of membrane proteins impact diverse cellular functions, including immune responses, receptor signaling, and protein homeostasis. Inhibition of MARCH6 can allow researchers to investigate the stability and turnover of specific membrane proteins and their effects on various cellular pathways. Understanding the intricacies of MARCH6 function through the use of inhibitors contributes to our knowledge of fundamental cellular processes and may have implications for future research and drug development efforts.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Inhibits N-linked glycosylation and could indirectly affect MARCH6 expression by inducing ER stress. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that could lead to reduced degradation of proteins, potentially impacting MARCH6 levels. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts ER-Golgi transport and could affect protein processing, indirectly influencing MARCH6 expression. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Induces ER stress by inhibiting the SERCA pump, which could affect MARCH6 expression. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Inhibits lysosomal degradation and autophagy, potentially affecting MARCH6 protein levels. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits eukaryotic protein synthesis, which could decrease MARCH6 protein levels by preventing translation. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Inhibits RNA synthesis by binding to DNA, which might lead to reduced transcription of MARCH6. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Inhibits RNA polymerase II, possibly decreasing MARCH6 mRNA and protein levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR signaling and could indirectly affect MARCH6 expression through modulation of protein synthesis. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Causes premature chain termination during protein synthesis, possibly leading to reduced MARCH6 protein levels. | ||||||